Wego Group and ConceptoMed signed Memorandum of Understanding

On the 8th of April 2017, in the presence of Her Excellency Erna Solberg, Prime Minister of Norway, on her first official visit to the People’s Republic of China, Wego Group and ConceptoMed AS signed a Memorandum of Understanding.

Wego Group and ConceptoMed wish to explore the possibility of entering into a business relationship, either manufacturing or other strategic collaboration.

Shandong Weigao Group Medical Polymer Co. Ltd. (Wego Group) and ConceptoMed have agreed to build a partnership for manufacturing and promoting Luer-Jack in the domestic Chinese market, as well as selected Asian markets. Wego Group and ConceptoMed will also explore the manufacturing, co-promotion and co-development of Luer-Jack and related technologies in other markets, where Luer-Jack is not yet currently available.

China is a key pillar to our global strategy, and Wego is an ideal strategic partner for us in China. We believe strategic opportunities will be valuable for both parties allowing us to leverage our combined strengths for success. Specifically, Wego Group’s strengths include an excellent reputation and a market leader position in China. ConceptoMed’s strengths include proprietary innovations in the medical consumables space”, commented Chairman of the Board of ConceptoMed, Mr. Runar Bjørklund.

We see the cooperation between Wego and ConceptoMed as an exciting combination of European design and Chinese manufacturing capability. ConceptoMed is bringing Norwegian technology to the Chinese market, and we see this as a great fit with Wego Group’s product portfolio and development efforts to make a real difference in injection safety – specifically the multiple benefits of LuerJack that can be integrated into high quality and unique product categories“, commented CEO and Executive Director of Wego Group, Mr. Wang Yi.

About Wego Group (http://www.weigaogroup.com) Shandong Weigao Group Medical Polymer Co. Ltd. (Wego Group) is based in Shandong province, PRC and listed on the Hong Kong Stock Exchange (HGK:1066).

Wego Group is a leading and innovative medical technology company with global presence, research and development and fully integrated value chain, mass-producing premium quality single-use medical devices. The Group has a wide range of innovative products, which include: consumables (infusion sets, syringes, medical needles, blood bags, pre-filled syringes, blood sampling products, and other consumables); orthopedic materials and blood purification consumables and equipment. The Group’s main production facilities are situated in Weihai, Shandong Province, PRC.

Wego Group is also a leader in the Chinese domestic syringe market, and sees high potential for promoting Luer-Jack, a novel and innovative multi-benefit syringe supporting prevention of needlestick injuries and Healthcare Acquired Infection.

山东威高集团医用高分子制品股份有限公司威高股份ConceptoMed签署谅解备忘录

201748威高股份和ConceptoMed AS在挪威首相Erna Solberg殿下的见证下签署谅解备忘录。这也是挪威首相Erna Solberg对中华人民共和国的首次正式访问。

威高股份和ConceptoMed有意探讨建立制造或其它战略合作业务关系的可能性。

威高股份和ConceptoMed同意相互合作以寻求在中国和选取的亚洲市场生产及推广Luer-Jack。威高股份和ConceptoMed也会在Luer-Jack还未销售的市场探索生产、共同推广及开发Luer-Jack及相关技术。

“中国是我们全球策略的重点,威高是我们在中国的一个理想战略伙伴。双方会在战略合作中发挥各自专长,互惠互利。威高股份在中国拥有极好的声誉,是中国的市场领导者。ConceptoMed拥有在医疗耗材领域的自主创新能力。“ConceptoMed的董事长Runar Bjørklund说。

“威高和ConceptoMed的合作是欧洲设计和中国制造的一次有机结合。ConceptoMed把挪威技术带到中国市场。我们认为ConceptoMed的技术和设计与威高的产品线及发展方向非常匹配,尤其是在安全注射领域,Luer-Jack很有潜力能够集成到我们的独创的、高端的产品线中。”威高股份首席执行官兼执行董事王毅先生说。

关于威高股份(http://www.weigaogroup.com)

山东威高集团医用高分子制品股份有限公司(威高股份)位于中国山东省,在香港联合交易所上市。

威高股份是一家领先的、具有创造力的医疗技术公司,在全球拥有销售和研发,生产高端一次性医疗设备,业务涉及整个产业链。威高股份有众多具有创造性的产品,包括:耗材(输液耗材、注射器、医用针头、血袋、预装填注射器、采血产品及其它耗材)、外科整形材料、血液净化耗材及设备。威高股份主要生产设施位于中国山东省威海市。

威高股份也是中国注射器市场的领导者,其认为推广独特的、有创造性的Luer-Jack具有潜力。Luer-Jack拥有多种优势,帮助防止针刺伤及医护过程中的感染。

ConceptoMed AS是一家ISO 13485认证的,有志向的医疗公司。公司通过其创新性的产品和独特的自主技术服务国际市场。我们创造聪明的帮助医护人员以及提高病人护理的医疗系统。简洁精练是我们的准则。我们勇敢、好奇、专注。我们关心这项事业。

团队位于挪威巴尔斯塔德,不断达到一个个里程碑并且持续增加国际活动。

获取更多公司信息及工作机会,请访问www.conceptomed.comwww.luerjack.com

关注我们的MyNewsdesk及领英。

Luer-Jack®ConceptoMed AS持有的注册商标。Luer-Jack®技术在全球受其来自8个专利族的60多件专利(授予及将授予)的专利保护。